A Prospective Post-Marketing Observational Study of Brivaracetam in People With Focal Epilepsy
Authors:
- Rayan YanesRYRayan Yanes
- Joel Neves BriardJBJoel Neves Briard
- Tang-Duc Jeremy NguyenTNTang-Duc Jeremy Nguyen
- Maya SultanemMSMaya Sultanem
- Dang Khoa NguyenDNDang Khoa Nguyen
- Steve GibbsSGSteve Gibbs
- Kristin IkedaKIKristin Ikeda
- Jeffrey JirschJJJeffrey Jirsch
- Colin JosephsonCJColin Josephson
- Lysa Boisse LomaxLLLysa Boisse Lomax
- Véronique CloutierVCVéronique Cloutier
- Mark KeezerMKMark Keezer
- 27 December 2023
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 51 (6) , 860-864
Abstract
We evaluated the effectiveness and tolerability of brivaracetam (BRV), an adjunctive antiseizure medication, as a treatment for focal epilepsy in adults. In this prospective study, we enrolled 51 participants from 3 sites across Canada. At 6 months, 68% (26/38) of participants were still taking BRV, among whom 35% (8/23) attained seizure freedom and 48% (11/23) saw their seizure frequency reduced by over 50%. We did not measure any significant change in irritability, quality of life, depression, and anxiety while treated with BRV. Our findings suggest BRV is effective in reducing seizure frequency among adults with focal epilepsy.Keywords
This publication has 10 references indexed in Scilit:
- Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studiesNeurology, 2016
- A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizuresEpilepsia, 2015
- The Brief Irritability Test (BITe)Assessment, 2014
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double‐blind, placebo‐controlled trialEpilepsia, 2013
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double‐blind, randomized, placebo‐controlled trialEpilepsia, 2013
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Rapid detection of major depression in epilepsy: a multicentre studyThe Lancet Neurology, 2006
- Bias: Table 1Journal of Epidemiology and Community Health, 2004
- A Brief Questionnaire to Screen for Quality of Life in Epilepsy The QOLIE‐10Epilepsia, 1996